Cargando…

Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance

Detalles Bibliográficos
Autores principales:	Lu, Jinmiao, Ying, Xiaohua, Li, Zhiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kerman University of Medical Sciences 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461880/ https://www.ncbi.nlm.nih.gov/pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972

Ejemplares similares

Comment on: “Forecasting Pharmaceutical Prices for Economic Evaluations When There is No Market: A Review”
por: Holko, Przemysław
Publicado: (2017)

Authors’ Reply to Holko: “Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review”
por: Akpinar, Ilke, et al.
Publicado: (2017)

Perspective: Industry–patient relationships for the promotion of pharmaceutical agents
por: Bryarly, Meredith A., et al.
Publicado: (2023)

The international drug price indicator guide: An objective source of information about medicine prices
por: Shankar, Pathiyil Ravi
Publicado: (2014)

Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014)

Comparison of Prices for Commonly Administered Drugs in Employer-Sponsored Insurance Relative to Medicare
por: Chang, Jessica Y., et al.
Publicado: (2023)

Effects of Law Regarding Prevention of Dishonest Solicitation on the Korean Pharmaceutical Industry
por: Yoon, Sung Man
Publicado: (2021)

A potentially serious adverse effect of GLP-1 receptor agonists
por: Lu, Jinmiao, et al.
Publicado: (2023)

The benefits of more government interference in prescription drug pricing
por: Houser, Ryan S.
Publicado: (2022)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015)

Pharmaceutical practice and selling of drugs during Ramadan
por: Jarrar, YazunB.
Publicado: (2011)

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2019)

Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices
por: Patel, Nisarg A.
Publicado: (2017)

The Medical Profession and the Insurance Bill
por: Daw, S. W.
Publicado: (1911)

Cigarette price and smoking
por: Tin, Sim Sai, et al.
Publicado: (2015)

Pharmaceutical companies as the funding sources for continuing medical education
por: Kanchan, Tanuj
Publicado: (2015)

An insight into the emerging role of regional medical advisor in the pharmaceutical industry
por: Gupta, Sandeep Kumar, et al.
Publicado: (2013)

Pricing in General Insurance
por: Parodi, Pietro
Publicado: (2014)

Consequences of Medical Insurance on Social Welfare; an Evidenced Based Study
por: Hadavand, Mohammad Bagher, et al.
Publicado: (2013)

Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
por: Aaron, Micah B., et al.
Publicado: (2021)

Taenia ovis: an emerging threat to the Chinese sheep industry?
por: Zheng, Yadong
Publicado: (2016)

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework
por: Moreno, Santiago G., et al.
Publicado: (2019)

Self-Medication Behaviors of Chinese Residents and Consideration Related to Drug Prices and Medical Insurance Reimbursement When Self-Medicating: A Cross-Sectional Study
por: Zhang, Ziwei, et al.
Publicado: (2022)

Healthcare activity as a major risk of dying of COVID-19: medical doctors pay the price
por: CARIATI, ANDREA, et al.
Publicado: (2021)

Comment on “binge drinking and alcohol prices”
por: Xuan, Ziming, et al.
Publicado: (2016)

The Price of Gas
por: Mason, W. M.
Publicado: (1916)

The Price of the Publican
Publicado: (1895)

Price of PRICE (Protection, Rest, Ice, Compression, and Elevation) redefined: a case of entrapment neuropathy in an individual with hemophilia
por: Patra, Pritish Chandra, et al.
Publicado: (2018)

National Insurance: The Distribution of the Medical Benefit Fund
por: Thyne, John Tod
Publicado: (1913)

Changes in Drug List Prices and Amounts Paid by Patients and Insurers
por: Yang, Eric J., et al.
Publicado: (2020)

Insight into Provider Payment Mechanisms in Healthcare Industry: A Case of Iran
por: BABASHAHY, Saeideh, et al.
Publicado: (2016)

Medical science and medical industry. The formation of the American pharmaceutical industry
por: Weatherall, M.
Publicado: (1988)

Retained foreign bodies: Vigilance is the price of safety
por: Gupta, Madhu, et al.
Publicado: (2013)

Reply to the critics on “binge drinking and alcohol prices”
por: Nelson, Jon P.
Publicado: (2016)

Depression, dependence and prices of the COVID-19-Crisis
por: Frank, Andreas, et al.
Publicado: (2020)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Variability in Prices Paid for Hemodialysis by Employer-Sponsored Insurance in the US From 2012 to 2019
por: League, Riley J., et al.
Publicado: (2022)

The Applications of Health Informatics in Medical Tourism Industry of Iran
por: REZAEI-HACHESU, Peyman, et al.
Publicado: (2017)

Metaverse: A Modern Approach to Medical Tourism Industry
por: Shaygani, Fatemeh, et al.
Publicado: (2022)

Comments on “Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses”
por: Greenfield, Tom
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vrqge5kr16e80a9ljsj0tutvgi